PolyPid LTD. is developing products based on a polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs and improve surgical results. The company's lead product candidate is D-PLEX100, to prevent sternal (bone) and abdominal (soft tissue) surgical site infections. PolyPid was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Name / Ticker | Price | Zen Rating |
---|---|---|
$13.95 | A | |
$41.34 | A | |
$12.40 | A |